PHI enters the US capital market - shares now also traded on OTCQB
Phase Holographic Imaging (PHI) announced its listing on the OTCQB Venture Market in the U.S., effective August 15, 2024, under the symbol PHIXF. This move is aimed at improving accessibility and engagement with U.S. investors, leveraging existing reporting standards to meet U.S. requirements. The listing signifies PHI’s growth and commitment to the U.S. market, enhancing trading transparency and liquidity.
Phase Holographic Imaging (PHI) ha annunciato la sua quotazione sul OTCQB Venture Market negli Stati Uniti, a partire dal 15 agosto 2024, con il simbolo PHIXF. Questa mossa è volta a migliorare l'accessibilità e il coinvolgimento con gli investitori statunitensi, sfruttando gli attuali standard di reporting per soddisfare i requisiti americani. La quotazione rappresenta la crescita di PHI e il suo impegno verso il mercato statunitense, migliorando la trasparenza e la liquidità delle negoziazioni.
Phase Holographic Imaging (PHI) anunció su cotización en el OTCQB Venture Market en los EE. UU., a partir del 15 de agosto de 2024, bajo el símbolo PHIXF. Este movimiento tiene como objetivo mejorar la accesibilidad y el compromiso con los inversores estadounidenses, aprovechando los estándares de informes existentes para cumplir con los requisitos estadounidenses. La cotización simboliza el crecimiento de PHI y su compromiso con el mercado estadounidense, mejorando la transparencia y la liquidez en el comercio.
Phase Holographic Imaging (PHI)는 2024년 8월 15일부터 OTCQB 벤처 마켓에 PHIXF 기호로 상장한다고 발표했습니다. 이 결정은 기존 보고 기준을 활용하여 미국 투자자와의 접근성과 참여를 개선하는 것을 목표로 합니다. 상장은 PHI의 성장과 미국 시장에 대한 헌신을 나타내며, 거래 투명성과 유동성을 향상시킵니다.
Phase Holographic Imaging (PHI) a annoncé sa cotation sur le OTCQB Venture Market aux États-Unis, à compter du 15 août 2024, sous le symbole PHIXF. Ce mouvement vise à améliorer l'accessibilité et l'engagement auprès des investisseurs américains, en tirant parti des normes de reporting existantes pour répondre aux exigences américaines. La cotation représente la croissance de PHI et son engagement envers le marché américain, améliorant ainsi la transparence et la liquidité des transactions.
Phase Holographic Imaging (PHI) hat seine Listung im OTCQB Venture Market in den USA für den 15. August 2024 unter dem Symbol PHIXF angekündigt. Dieser Schritt zielt darauf ab, die Zugänglichkeit und das Engagement bei US-Investoren zu verbessern, indem bestehende Berichtstandards genutzt werden, um die US-Anforderungen zu erfüllen. Die Listung steht für das Wachstum von PHI und das Engagement für den US-Markt und verbessert die Handels-Transparenz und Liquidität.
- PHI's listing on the OTCQB Venture Market increases accessibility for U.S. investors.
- Trading on the OTCQB is expected to enhance liquidity and visibility.
- PHI met financial standards and corporate governance to qualify for OTCQB listing.
- None.
Effective August 15th, PHI has been admitted to trading on the OTCQB under the symbol "PHIXF". OTC Markets Group operates regulated markets for trading
PHI, already listed on the Spotlight Stock Market, can use its existing reporting standards to meet
PHI's CEO, Patrik Eschricht, comments:
"We are excited to expand our market presence by listing on the OTCQB. This new platform offers our investors greater accessibility and visibility in the U.S. market, aligning with our mission to advance regenerative medicine. This dual listing is expected to enhance liquidity, provide greater value to our shareholders, and support the continued growth of PHI."
For more information contact:
Lisa Bodily, Head of IR, ir@phiab.com, +46 73 026 87 87
About PHI
Phase Holographic Imaging (PHI) is a medical technology company that develops and markets its non-invasive time-lapse imaging instruments for long-term quantitative analysis of living cells. The foundation of PHI's current commercial HoloMonitor® products is Quantitative Phase Imaging (QPI) technology — an innovative approach to cell quality evaluation. QPI offers detailed analysis of cell characteristics without harming the cells, avoiding the limitations of traditional measurement methods. PHI is actively focusing on business development to expand from pre-clinical research to the clinical market and the emerging regenerative medicine field. PHI envisions transforming live cell analysis and establishing QPI as a standard for cell quality control, making future cell therapies safe, affordable, and accessible for patients. PHI is based in
Photo: https://mma.prnewswire.com/media/2483603/PHI_AB_OTCQB.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/phi-enters-the-us-capital-market--shares-now-also-traded-on-otcqb-302224242.html
SOURCE Phase Holographic Imaging PHI AB
FAQ
What is the significance of PHI's listing on the OTCQB Venture Market?
When did PHI begin trading on the OTCQB under the symbol PHIXF?
How does PHI's OTCQB listing affect its reporting standards?
What financial and governance criteria did PHI meet to qualify for OTCQB?
